|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.23||2.18 (+3.63%)||47.55 - 70.54||13.5 million (Above Avg)|
Market data as of 4:00PM 10/02/15. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
10/01/2015 6:59 AM ET
REPEAT/Actor Jack Huston Challenges Europeans to Take ACTion Against Lung Cancer
09/28/2015 3:30 AM ET